Candidate for Treasurer
Successful financial governance is core to ASAM’s continued success. As your Treasurer, I serve crucial roles in ASAM’s governance to emphasize the financial implications of our leadership decisions, ensure ASAM’s financial position is clear to decision makers, and monitor of the congruence between our financial management and the intentions of the Board. I seek your re-election to continue as ASAM’s Treasurer.
1. What are your greatest contributions to ASAM and the field of addiction medicine?
- Applying Our Resources to Maximize ASAM’s Impact – As your 2015-2017 treasurer, I have been guiding ASAM’s governance with the fiduciary responsibility to ASAM and our membership. Since taking office, we have grown our membership and budget and have modernized our investment policies to protect our growing reserve funds. As treasurer, I’ve facilitated governance’s directive to apply our budget surplus to advance ASAM’s urgent policy initiatives, which directly contributed to the enactment of the Comprehensive Addiction and Recovery Act and the introduction of The Recovery Enhancement for Addiction Treatment Act on the Senate floor. I’m proud to serve in the critical role of treasurer during this extraordinary period of growth for ASAM.
- ASAM’s ED/CEO - I served on the ED/CEO Search committee that selected ASAM’s current Executive Director, Penny Mills. Penny has done a tremendous job of transforming ASAM; I was fortunate to have seen that potential in 2010 during Penny’s selection. To date, participating in Penny’s selection and onboarding will likely be my most significant contribution to ASAM.
- Associate Membership – I facilitated the ongoing board discussion that led to ASAM’s establishment of the Associate Membership category for non-physicians. The diversification of our membership and ongoing refinement of membership categories will likely be my most enduring contribution to ASAM as co-chair of ASAM’s membership committee.
2. How would your election benefit ASAM and the field of addiction medicine?
- Continued solid financial governance - ASAM’s finances require board leadership working in collaboration with ASAM’s executive director to ensure our reserves our built and we maximize our financial capacity. ASAM’s impending office space transition will bring challenges to our society, and in evaluating the risks inherent to this change. As treasurer, I continue to bring practical, hands-on experience in facilitating the decision making process that combines both the expertise of our executives alongside the board-driven strategic direction. My background as your current treasurer and as a long-time member of association governance in a variety of organizations positions me well to serve in this role. ASAM’s treasurer serves during a critical time for ASAM and during this transformative era for addiction medicine. Maintaining a strong professional society is essential for our field.
- Actionable information for the board – As treasurer, I have and will continue to serve as a force for clarity to distill the complexity of ASAM’s financial data into information that is actionable for ASAM’s board, committees, and membership. I have driven dash-board formatting of financial statements so that board members can assess ASAM’s financial position at a glance, and clearly appreciate the financial advantages and disadvantages associated with our decisions. Prudence is crucial in making informed strategic decisions, and I am and will continue to be the treasurer that ensures governance and executive leadership have full awareness of financial implications in the decision making process.
Brian Hurley, MD, MBA, DFASAM is an addiction physician, current treasurer of ASAM, and a UCLA Robert Wood Johnson Foundation Clinical Scholar. He is board certified by ABAM in addiction medicine and by ABPN in psychiatry and addiction psychiatry. He completed a fellowship program in addiction psychiatry at New York University School of Medicine and residency training at the Massachusetts General Hospital and McLean Hospital (MGH-McLean), where he was the Chief Resident in Addiction Psychiatry. Brian is a graduate of the Keck School of Medicine and Marshall School of Business of the University of Southern California with both M.D. and M.B.A. degrees. He joined ASAM in 2002 as a first year medical student, and has served on the ASAM Board of Directors in various capacities since 2003. He served as the co-chair of ASAM's Membership Committee from 2008-2015, and spent two years as a member of ASAM’s finance committee before becoming chair of this committee in 2015 in his current role as treasurer. Prior to 2008, Brian served as chair of ASAM’s Physicians-in-Training Committee Chair and is formerly ASAM’s alternate delegate to the American Medical Association. Brian additionally served on the EVP/CEO search committee in 2010 that led to Penny Mill’s selection as ASAM’s current EVP/CEO. He has additional served in various roles for the Massachusetts Society of Addiction Medicine, New York Society of Addiction Medicine, and California Society of Addiction Medicine.
Aside from ASAM, Brian is a former National President and Director of Student Programming for the American Medical Student Association (AMSA); roles through which Brian has been an invited speaker at medical schools throughout the world addressing topics ranging from global health equity, healthcare reform, pharmaceutical advertising and ethics, lesbian gay bisexual and transgender equality, and medical student wellness. In addition to his work at ASAM, Brian serves on the American Medical Colleges’ Lesbian, Gay, Bisexual, Transgender and Differences of Sexual Development (LGBT+DSD) Patient Care Advisory Committee’s Ad-Hoc Committee on the Learning Environment. He is GLMA’s delegate to the American Medical Association's (AMA's) House of Delegates and serves on the Board of Directors of GLMA. Brian is also the immediate past chair of the AMA's Gay Lesbian Bisexual and Transgender Advisory Committee. Brian previously served on the Board of Trustees of the American Psychiatric Association (APA) during a period of significant organizational transition including the release of DSM-5 and the selection of new APA Medical Director / CEO Saul Levin, MD. Brian dedicates his career demonstrating the transformative impact addiction medicine has when integrated throughout healthcare.